Brief: Ascletis Pharma Announces A Supply Agreement Of Ritonavir Tablets With Simcere Pharmaceutical
17/01/2023 09:02
Jan 17 (Reuters) - Ascletis Pharma Inc 1672.HK :
* ASCLETIS ANNOUNCES ENTERING INTO A SUPPLY AGREEMENT OF
RITONAVIR
TABLETS WITH SIMCERE
* UNIT HAS ENTERED INTO SUPPLY AGREEMENT OF RITONAVIR
TABLETS WITH
HAINAN SIMCERE PHARMACEUTICAL CO.
Source text for Eikon: ID:nHKS6Yxxmz
Further company coverage: 1672.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660